Tandem Diabetes Care's market value continues to decline, failing to catch a bid at current levels. Q2 FY'23 results show a decline in pump shipments and revenues, with potential headwinds for future ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results